Evaluation of two-test serodiagnostic method for early lyme disease in clinical practice

Journal of Infectious Diseases

Volumn 179, Issue 4, 1999, Pages 931-938

  Trevejo, Rosalie T ^a   Krause, P J ^b   Sikand, V K ^b   Schriefer, M E ^b   Ryan, R ^b   Lepore, T ^b   Porter, W ^b   Dennis, D T ^b  

^a Humane Society of Sonoma County Animal Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; CHILL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; ERYTHEMA CHRONICUM MIGRANS; FATIGUE; FEMALE; HEADACHE; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYME DISEASE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0032959530     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314663     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention. Lyme disease - United States, 1996. MMWR Morb Mortal Wkly Rep 1997; 46:531-5.
2. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46(RR-10):20-1.
3. Ley C, Chinh L, Olshen EM, Reingold AL. The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA 1994; 271: 460-3.
4. Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA 1998; 279:206-10.
5. Reid MC, Schoen RT, Evans J, Rosenburg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998; 128:354-62.
6. Schwartz BS, Goldstein MD, Ribeiro JM, Schulze TL, Shahied SI. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA 1989; 262:3431-4.
7. Hedburg CW, Osterholm MT, MacDonald KL, White KE. An interlaboratory study of antibody to Borrelia burgdorferi. J Infect Dis 1987; 155: 1325-7.
8. Bakken LL, Case KL, Callister SM, Bourdeau NJ, Schell RF. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 1992; 268:891-5.
9. Craven RB, Quan TJ, Bailey RE, et al. Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation. Emerg Infect Dis 1996; 2:136-40.
10. Johnson BJ, Robbins KE, Bailey, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 1996; 174:346-53.
11. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392-400.
12. Association of State and Territorial Public Health Laboratory Directors. Proceedings of the Second National Conference on Serologic Diagnosis of Lyme Disease. Washington, DC: ASTPHLD, 1994:1 111.
13. Centers for Disease Control. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44:590-1.
14. Campbell GL, Paul WS, Schriefer ME, Craven RB, Robbins KE, Dennis DT. Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri, 1990-1993. J Infect Dis 1995; 172:470-80.
15. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: Wiley, 1981
16. American College of Physicians. Guidelines for the laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127:1106-8.
17. Ledue TB, Collins MF, Craig WY. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J Clin Microbiol 1996; 34:2343-50.
18. Strickland GT, Karp AC, Mathews A. Utilization and cost of serologic tests for Lyme disease in Maryland. J Infect Dis 1997; 176:819-21.
19. Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127:1109-23.
20. Feder HM, Whitaker DL. Misdiagnosis of erythema migrans. Am J Med 1995; 99:412-9.
21. Shrestha M, Grodzicki RL, Steere AC. Diagnosing early Lyme disease. Am J Med 1985; 78:235-40.
22. Kirkland KB, Klimko TB, Meriwether RA, et al. Erythema migrans-like rash illness at a camp in North Carolina. Arch Intern Med 1997; 157:2635-41.
23. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988; 319:1441-6.
24. Rand PW, Lacombe EH, Smith RP Jr. Gensheimer K, Dennis DT. Low seroprevalence of human Lyme disease near a focus of high entomologic risk. Am J Trop Med Hyg 1996; 55:160-4.
25. Jaeschke R, Guyatt GH, Sackett DL. User's guide to the medical literature. JAMA 1994; 271:703-7.
26. Aguero-Rosenfeld ME, Nowakowski J, MCKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J Clin Microbiol 1993; 31:3090-5.
27. Aguero-Rosenfeld MA, Nowakowshi J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996; 34:1-9.
28. Sivak S, Aguero-Rosenfeld ME, Nowakowski, Nadelman RB, Wormser GP. Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease. Arch Intern Med 1996; 156:2105-9.
29. Hilton E, Devoti J, Sood S. Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease. J Clin Microbiol 1996; 34:1353-4.
30. de Silva AM, Telford SR 3rd, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 1996; 183:271-5.
31. Craft JE, Fischer DK, Shimamoto GT, Steere AC. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest 1986; 78:934-9.
32. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995; 33:419-27.
33. Hauser U, Lenhert G, Wilske B. Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme disease. Clin Diagn Lab Immunol 1998; 5:456-62.
34. Kowal K, Weinstein A. Western blot band intensity analysis. Application to the diagnosis of Lyme arthritis. Arthritis Rheum 1994; 37:1206-11.
35. Wormser GP. Prospects for a vaccine to prevent Lyme disease in humans. Clin Infect Dis 1995; 21:1267-74.
36. Zhang YQ, Mathiesen D, Kolbert CP, Anderson J, Schoen RT, Fikrig E. Persing DH. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection. J Clin Microbiol 1997; 35:233-8.